跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LYNPARZA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LYNPARZA
Authorized
STANDARD
LYNPARZA
astrazeneca canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2d037530929b292b
Company
astrazeneca canada inc
Type
Standard
Approval Details
Approval Id
2d037530929b292b
Drug Approval Canada Name
LYNPARZA
Product Name
LYNPARZA
Status
Marketed
Status Date
2018-05-23
Original Market Date
2018-05-23
Din
02475200
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XK01 OLAPARIB
Atc Name
l 01 xk 01
Aig Number
0158110002
Company Name
astrazeneca canada inc
Company Address
1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4
Active Ingredients
OLAPARIB
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2d037530929b292b
Type
Standard
Back to Health Canada Approvals